Neuronetics to Report First Quarter 2026 Financial and Operating Results and Host Conference Call
Neuronetics, a medical technology firm specializing in neurohealth treatments, will report its first quarter 2026 financial and operating results on May 5, 2026, accompanied by a conference call. The company markets the NeuroStar Advanced Therapy System, a leading FDA-cleared TMS treatment for major depressive disorder and other neurohealth conditi…